Acutus Medical AFIB
$ 0.09
-26.83%
Quarterly report 2024-Q3
added 11-14-2024
Acutus Medical Balance Sheet 2011-2024 | AFIB
Annual Balance Sheet Acutus Medical
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
14.2 M | 9.17 M | 16.7 M | 25.1 M | 31.7 M | 16.2 M | - | - | - | - | - | - | - |
Long Term Debt |
32.7 M | 34.4 M | 40.4 M | 39 M | 38.2 M | 14.6 M | - | - | - | - | - | - | - |
Long Term Debt Current |
718 K | 319 K | 395 K | 933 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 44 M | 299 M | 133 M | - | - | - | - | - | - | - |
Total Current Liabilities |
18.9 M | 19.9 M | 18.5 M | 21.9 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
54.8 M | 58.4 M | 64.1 M | 66 M | 331 M | 158 M | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | 401 K | 301 K | 311 K | 318 K | - | - | - | - | - | - | - |
Retained Earnings |
-600 M | -518 M | -479 M | -361 M | -259 M | -162 M | - | - | - | - | - | - | - |
Total Assets |
54 M | 133 M | 170 M | 193 M | 105 M | 25.9 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
19.2 M | 25.6 M | 24.1 M | 25.2 M | 9.6 M | - | - | - | - | - | - | - | - |
Book Value |
-879 K | 75 M | 106 M | 127 M | -226 M | -132 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
-879 K | 75 M | 106 M | 127 M | -226 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Acutus Medical
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
25.3 M | 25.1 M | 32.8 M | 32.7 M | 34.8 M | 34.6 M | 34.5 M | 34.4 M | 34.3 M | 34.2 M | 40.8 M | 40.4 M | 40 M | 39.7 M | 39.3 M | 39 M | 39 M | 39 M | 39 M | 38.2 M | 38.2 M | 38.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
42.5 M | 40.3 M | 45.7 M | 54.8 M | 53 M | 56.6 M | 55.5 M | 58.4 M | 56.8 M | 61.7 M | 62.9 M | 64.1 M | 63.7 M | 64.7 M | 61.7 M | 66 M | 66 M | 66 M | 66 M | 77.9 M | 77.9 M | 77.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | 349 K | 342 K | 297 K | 326 K | 571 K | 278 K | 430 K | 401 K | 379 K | 304 K | 479 K | 301 K | 301 K | 301 K | 301 K | 311 K | 311 K | 311 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-608 M | -603 M | -602 M | -600 M | -566 M | -553 M | -535 M | -518 M | -533 M | -513 M | -519 M | -479 M | -447 M | -419 M | -390 M | -361 M | -361 M | -361 M | -361 M | -259 M | -259 M | -259 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
32.2 M | 35.5 M | 41.7 M | 54 M | 84.7 M | 100 M | 116 M | 133 M | 115 M | 138 M | 132 M | 170 M | 197 M | 141 M | 162 M | 193 M | 193 M | 193 M | 193 M | 105 M | 105 M | 105 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
12.6 M | 13.3 M | 18.5 M | 19.2 M | 31.1 M | 30.1 M | 29.9 M | 25.6 M | 32.2 M | 50.7 M | 12.5 M | 24.1 M | 58.6 M | 7.28 M | 8.63 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | 9.45 M | 9.45 M | 9.45 M | - | 9.78 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
-10.3 M | -4.8 M | -4.02 M | -879 K | 31.7 M | 43.7 M | 60.5 M | 75 M | 57.8 M | 76.7 M | 68.8 M | 106 M | 134 M | 75.9 M | 100 M | 127 M | 127 M | 127 M | 127 M | 27.5 M | 27.5 M | 27.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-10.3 M | -4.8 M | -4.02 M | -879 K | 31.7 M | 43.7 M | 60.5 M | 75 M | 57.8 M | 76.7 M | 68.8 M | 106 M | 134 M | 75.9 M | 100 M | 127 M | 127 M | 127 M | 127 M | -226 M | -226 M | -226 M | -146 M | -132 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency